Barrett's Esophagus and Barrett's-Related Dysplasia

Barrett's esophagus is a complication of chronic gastroesophageal reflux disease and can be diagnosed when there is an endoscopic abnormality in which a biopsy shows evidence of specialized columnar epithelium, characterized by the presence of acid mucin-containing goblet cells. Much of the controversy in this body of literature relates to the complex anatomy of the esophagogastric junction and the difficulty in precisely identifying this landmark at endoscopy. By definition, in Barrett's esophagus, the squamocolumnar junction is proximal to the esophagogastric junction. Although fundic-type or cardiac-type (junctional) columnar epithelium may be present in Barrett's esophagus, it is only the presence of specialized columnar epithelium that is diagnostic of this condition. Patients with Barrett's esophagus are at risk of progressing to esophageal dysplasia and adenocarcinoma. There are several problems with using dysplasia as a marker for increased cancer risk in these patients, including problems with sampling error and intra- and interobserver variation in the recognition of dysplasia. It may be difficult to distinguish regenerative epithelial changes from dysplasia, low-grade from high-grade dysplasia, and high-grade dysplasia from intramucosal adenocarcinoma. Finally, there are relatively few prospective data evaluating the natural history of high-grade dysplasia. The management of patients with Barrett's-related dysplasia is controversial and varies from institution to institution. Future emphasis should be on cost-effective techniques for sampling as much of the esophageal mucosa as possible in patients who are at the highest risk of progressing to dysplasia and adenocarcinoma. Identification of biomarkers that identify such patients before the histologic recognition of dysplasia will be an area of intensive research.

[1]  R. Lebovitz,et al.  p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.

[2]  S. Medendorp,et al.  Superficial esophageal carcinoma. , 1995, The Annals of thoracic surgery.

[3]  Edward L. Lee,et al.  In situ hybridization for the detection of telomerase RNA in the progression from barrett's esophagus to esophageal adenocarcinoma , 1998, Cancer.

[4]  Prateek Sharma,et al.  Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[5]  D. Kerr,et al.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.

[6]  J. Peters,et al.  Definition of histopathologic changes in gastroesophageal reflux disease. , 2000, The American journal of surgical pathology.

[7]  A. Younes,et al.  Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. , 1999, Human pathology.

[8]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.

[9]  S. Groshen,et al.  Carditis: A Manifestation of Gastroesophageal Reflux Disease , 2001, The American journal of surgical pathology.

[10]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[11]  B. Reid,et al.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.

[12]  L. Johnson,et al.  Barrett's esophagus: a review. , 1983, The American journal of medicine.

[13]  R. Riddell Dysplasia in inflammatory bowel disease. , 1980, Clinics in gastroenterology.

[14]  Brian J. Reid,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort , 1992 .

[15]  Stephen S. Sternberg,et al.  Histology for Pathologists , 1992, Annals of Internal Medicine.

[16]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[17]  J. Peters,et al.  Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. , 1997, Annals of surgery.

[18]  G. Chejfec,et al.  Adenocarcinomas arising in tongues or short segments of Barrett's esophagus , 2005, Digestive Diseases and Sciences.

[19]  R. Lee Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients , 1985, The American journal of surgical pathology.

[20]  J. Goldblum,et al.  The gastric cardia: fact or fiction? , 2000, American Journal of Gastroenterology.

[21]  R. Haggitt Adenocarcinoma in Barrett's esophagus: a new epidemic? , 1992, Human pathology.

[22]  P. Blount,et al.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. , 2000 .

[23]  M. Bains,et al.  Adenocarcinoma in Barrett's esophagus. , 1983, The Journal of thoracic and cardiovascular surgery.

[24]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[25]  Blot Wj,et al.  Esophageal cancer trends and risk factors. , 1994 .

[26]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[27]  A. Ippoliti,et al.  The diagnosis of Barrett's esophagus: goblets, goblets, goblets. , 1996, Gastrointestinal endoscopy.

[28]  R. Haggitt,et al.  Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.

[29]  D. Dillard,et al.  Muscular anatomy of the gastroesophageal junction and role of phrenoesophageal ligament; autopsy study of sphincter mechanism. , 1966, Annals of surgery.

[30]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[31]  F. Offner,et al.  Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. , 1996, Human pathology.

[32]  S. Spechler,et al.  Barrett's esophagus. , 1994, Seminars in oncology.

[33]  P. Chandrasoma,et al.  Histology of the gastroesophageal junction: an autopsy study. , 2000, The American journal of surgical pathology.

[34]  J. Goldblum,et al.  Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. , 1999, Gastrointestinal endoscopy.

[35]  W. Hop,et al.  Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus , 1993, Cancer.

[36]  R. Sampliner,et al.  Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.

[37]  T. Rice,et al.  Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.

[38]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[39]  F. Ellis,et al.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. , 1978, American journal of clinical pathology.

[40]  G. Thomas,et al.  TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. , 1994, Gastroenterology.

[41]  Carissa A. Sanchez,et al.  Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. , 1993, Gastroenterology.

[42]  M. Koike,et al.  Histopathologic characteristics of early stage esophageal carcinoma: A comparative study with gastric carcinoma , 2010, Cancer.

[43]  D. Skinner,et al.  Dysplasia in Barrett's esophagus , 2004, Journal of Cancer Research and Clinical Oncology.

[44]  J. Roth,et al.  p53 gene mutations in Barrett's epithelium and esophageal cancer. , 1991, Cancer research.

[45]  R. Cherian,et al.  Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. , 1996, The American journal of gastroenterology.

[46]  W H Henricks,et al.  Observer variation in the diagnosis of superficial oesophageal adenocarcinoma , 2002, Gut.

[47]  R. Sampliner,et al.  Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. , 1989, Gastroenterology.

[48]  J. Boitnott,et al.  The spectrum of carcinoma arising in Barrett's esophagus: A clinicopathologic study of 26 patients , 1984, The American journal of surgical pathology.

[49]  R. Wong,et al.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.

[50]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[51]  R. R. Smith,et al.  The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. , 1987, American journal of clinical pathology.

[52]  B. Reid,et al.  Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. , 1988, Gastroenterology.

[53]  R. Goyal,et al.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.

[54]  M. Sivak,et al.  Barrett's esophagus. A review of the pathologist's role in diagnosis and management. , 1991, Pathology annual.

[55]  Tarun Mullick Telomerase upregulation in Barrett’s esophagus precedes the development of esophageal adenocarcinoma , 2001 .

[56]  S. Hamilton,et al.  Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. , 1998, The American journal of pathology.